- Home
- SEED vs SNOA Comparison
SEED vs SNOA Comparison
Compare SEED & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEED
- SNOA
- Stock Information
- Founded
- SEED 1997
- SNOA 1999
- Country
- SEED China
- SNOA United States
- Employees
- SEED N/A
- SNOA N/A
- Industry
- SEED Farming/Seeds/Milling
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- SEED Consumer Staples
- SNOA Health Care
- Exchange
- SEED Nasdaq
- SNOA Nasdaq
- Market Cap
- SEED 6.9M
- SNOA 6.4M
- IPO Year
- SEED N/A
- SNOA 2007
- Fundamental
- Price
- SEED $0.99
- SNOA $3.00
- Analyst Decision
- SEED
- SNOA
- Analyst Count
- SEED 0
- SNOA 0
- Target Price
- SEED N/A
- SNOA N/A
- AVG Volume (30 Days)
- SEED 77.6K
- SNOA 52.3K
- Earning Date
- SEED 06-26-2025
- SNOA 08-07-2025
- Dividend Yield
- SEED N/A
- SNOA N/A
- EPS Growth
- SEED N/A
- SNOA N/A
- EPS
- SEED N/A
- SNOA N/A
- Revenue
- SEED $12,910,081.00
- SNOA $14,912,000.00
- Revenue This Year
- SEED N/A
- SNOA $23.00
- Revenue Next Year
- SEED N/A
- SNOA $24.59
- P/E Ratio
- SEED N/A
- SNOA N/A
- Revenue Growth
- SEED N/A
- SNOA 17.43
- 52 Week Low
- SEED $0.74
- SNOA $1.75
- 52 Week High
- SEED $3.59
- SNOA $5.93
- Technical
- Relative Strength Index (RSI)
- SEED 47.92
- SNOA 41.42
- Support Level
- SEED $0.96
- SNOA $2.88
- Resistance Level
- SEED $1.10
- SNOA $3.16
- Average True Range (ATR)
- SEED 0.10
- SNOA 0.22
- MACD
- SEED 0.00
- SNOA -0.04
- Stochastic Oscillator
- SEED 26.67
- SNOA 20.20
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.